In contrast, esketamine treatment exhibited opposite impacts on these proteins, evidenced by increased Bcl-2 expression and decreased expressions of Bax and cleaved-caspase 3 in the lung tissues of ARDS mice receiving esketamine treatment (Fig. 4B). The gene discussed is BCL2; the disease is acute respiratory distress syndrome.